Aim: The effects of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in hereditary transthyretin amyloidosis (ATTRv) remain uncertain. The gene discussed is GLP1R; the disease is Familial transthyretin-related amyloidosis.